Clinical Trial Update: Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes

View source ↗

Summary

This clinical trial update notes that the Higashi-Saitama trial evaluating pioglitazone for cardiovascular outcomes in patients with type 2 diabetes has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Dyslipidemia
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Dokkyo Medical University | Conditions: Type 2 Diabetes, Hypertension | Status: COMPLETED